Evidence map›Paper›PMID 39504272›Full record

ArticleAnesthesia and analgesia2025

Development and Validation of a Predictive Model for Maternal Cardiovascular Morbidity Events in Patients With Hypertensive Disorders of Pregnancy.

Marie-Louise Meng, Yuqi Li, Matthew Fuller, Quinn Lanners, Ashraf S Habib, Jerome J Federspiel, Johanna Quist-Nelson, Svati H Shah, Michael Pencina, Kim Boggess and 2 more

Abstract readValidation Study
In one paragraph

Article in Anesthesia and analgesia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Marie-Louise MengFrom the Department of Anesthesiology, Duke University School of Medicine, Durham, North Carolina.
Yuqi LiDepartment of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, North Carolina.
Matthew FullerFrom the Department of Anesthesiology, Duke University School of Medicine, Durham, North Carolina.
Quinn LannersDepartment of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, North Carolina.
Ashraf S HabibFrom the Department of Anesthesiology, Duke University School of Medicine, Durham, North Carolina.
Jerome J FederspielDivision of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Duke University School of Medicine, Durham, North Carolina.
Johanna Quist-NelsonDivision of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of North Carolina, Chapel Hill, North Carolina.
Svati H ShahDepartment of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, North Carolina.
Michael PencinaDepartment of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, North Carolina.
Kim BoggessDivision of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of North Carolina, Chapel Hill, North Carolina.
Vijay KrishnamoorthyFrom the Department of Anesthesiology, Duke University School of Medicine, Durham, North Carolina.
Matthew EngelhardDepartment of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, North Carolina.

Funding

Support for QA/QC for Prior Approval ProcessUL1TR002553 · NCATS · DUKE UNIVERSITY · PI LI, JENNIFER S, MCNAMARA, JAMES O. · 2018 to 2023
$58.5M
Duke Women's Reproductive Health Research ScholarsK12HD103083 · NICHD · DUKE UNIVERSITY · PI Cindy Amundsen · 2020 to 2026
$2.2M
Machine Learning Methods to Develop and Deploy Real-Time Risk Surveillance for Autism Spectrum Disorder and Attention Deficit Hyperactivity Disorder from the Electronic Health RecordK01MH127309 · NIMH · DUKE UNIVERSITY · PI Matthew Morrow Engelhard · 2022 to 2026
$842k
Impacts of Cost Sharing and Echocardiography on Outpatient Care of Heart FailureF30HL110483 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI FEDERSPIEL, JEROME JEFFREY · 2011 to 2014
$133k
NCATS NIH HHS UL1 TR002553NICHD NIH HHS K12 HD103083NIMH NIH HHS K01 MH127309
6 · The paper itself

Abstract

backgroundHypertensive disorders of pregnancy (HDP) are a major contributor to maternal morbidity, mortality, and accelerated cardiovascular (CV) disease. Comorbid conditions are likely important predictors of CV risk in pregnant people. Currently, there is no way to predict which people with HDP are at risk of acute CV complications. We developed and validated a predictive model for all CV events and for heart failure, renal failure, and cerebrovascular events specifically after HDP.

methodsModels were created using the Premier Healthcare Database. The inclusion criteria for the model dataset were delivery with an HDP with discharge from October 1, 2015 to December 31, 2020. Machine learning methods were used to derive predictive models of CV events occurring during delivery hospitalization (Index Model) or during readmission (Readmission Model) using a training set (60%) to estimate model parameters, a validation set (20%) to tune model hyperparameters and select a final model, and a test set (20%) to evaluate final model performance.

resultsThe total model cohort consisted of 553,658 deliveries with an HDP. A CV event occurred in 6501 (1.2%) of the delivery hospitalizations. Multilabel neural networks were selected for the Index Model and Readmission Model due to favorable performance compared to alternatives. This approach is designed for prediction of multiple events that share risk factors and may cooccur. The Index Model predicted all CV events with area under the receiver operating curve (AUROC) 0.878 and average precision (AP) 0.239 (cerebrovascular events: AUROC 0.941, heart failure: AUROC 0.898, and renal failure: AUROC 0.885). With a positivity threshold set to achieve ≥90% sensitivity, model specificity was 65.0%, 83.5%, 68.6%, and 65.6% for predicting all CV events, cerebrovascular events, heart failure, and renal failure, respectively. CV events within 1 year of delivery occurred in 3018 (0.6%) individuals. The Readmission Model predicted all CV events with AUROC 0.717 and AP 0.022 (renal failure: AUROC 0.748, heart failure: AUROC 0.734, and cerebrovascular events AUROC 0.698). Feature importance analysis indicated that the presence of chronic renal disease, cardiac disease, pulmonary hypertension, and preeclampsia with severe features had the greatest effect on the prediction of CV events.

conclusionsAmong individuals with HDP, our multilabel neural network model predicted CV events at delivery admission with good classification and events within 1 year of delivery with fair classification.

Indexed as

Cardiovascular DiseasesHypertension, Pregnancy-InducedAdultDatabases, FactualFemaleHeart FailureHumansMachine LearningMorbidityPatient ReadmissionPredictive Value of TestsPregnancyReproducibility of ResultsRisk AssessmentRisk Factors

Identifiers

PMID39504272
PMCPMC12053508

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.